Search Results 31-40 of 15913 for GLP-1 agonist
Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists - is ...
The purpose of this study is to determine the contribution of islet GLP-1 to islet function in people with and without diabetes-associated genetic variation in ...
The purpose of this study is to determine the contribution of islet GLP-1 to islet function in prediabetes. Participation eligibility. Participant ...
Using combined therapy to treat obesity, combining bariatric surgery, also called metabolic surgery, with GLP-1 medications. Learn more.
Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications. For ...
... GLP-1 agonists reduce mortality vs control or DPP-4 inhibitors. Ann Intern ... Gonadotropin-releasing hormone agonist-induced pituitary apoplexy.
Regional gut transit delays on glucagon-like peptide-1 agonists in relation to clinical and pharmacologic factors. Clin Gastroenterol Hepatol (In press). 2025.
Glucagon-like peptide 1 (GLP-1) receptor agonists such as semaglutide ... If you have this procedure done on one eye, you may notice improvement in both eyes.
... glucagon-like peptide 1 (GLP-1) agonists due to their additional benefits in glucose management. Guidance for ...
GLP-1RA Use and Thyroid Cancer Risk. JAMA Otolaryngol Head Neck Surg. 2025 ... Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.